Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.31%, DAX30 +0.50%, CAC40 +0.27%

Jul 18 ,2025

  • Synopsis

    • European indices are set open higher as Asian equities trade mostly higher Friday. Tech platforms driving Hang Seng towards fresh March highs. TSMC underpinning Taiex's advance. ASX the other notable gainer. Japan and Korean benchmarks weaker

    • US equities were higher in Thursday trading as stocks finished near best levels. S&P 500 and Nasdaq Composite also posted fresh record closes.

    • EU scrambling after US President Trump threatened 30% tariff on goods imported from the bloc from 1-Aug. Irish Deputy PM Harris revealed a trade deal "tantalisingly close" before Trump's tariff threat arrived

    • Macroeconomic releases so far today: Germany Jun PPI (1.3%) y/y vs consensus (1.3%) and prior (1.2%)

    • Other economic due today: Spain May trade balance, Eurozone May construction output

    • Corporate earnings came mostly from Sweden this morning: Instalco, Tomra Systems, Truecaller, Modern Times Group, SKF, Wartsila, Kone, Danske Bank, Saab, CellaVision, Telenor, Husqvarna, Electrolux, Skanska.

    • Trading Update expected at 7am. Burberry Group (BRBY.LN)

  • Politics/Macro/World News

    • ECB May Wait Until December to Make Final Rate Cut, Survey Shows (Bloomberg )

    • UK and Germany hail wide-ranging treaty, deepening ties in face of threats (Reuters )

    • ECB faces rate cut dilemma amid trade uncertainty (Bloomberg )

  • Top company news

    • Earnings/updates

      • GSK.LN (GSK Plc) -- provides update/response on FDA advisory committee review and vote against benefit-risk profiles of Blenrep combinations

      • ELUX.B.SS (Electrolux) -- reports Q2 EPS SEK0.65 vs consensus SEK0.81; FY outlook unchanged

      • DG.FP (VINCI SA) -- Vinci reports Q2 airport passenger traffic +6.7%

      • SCHP.SW (Schindler Holding) -- reports Q2 EPS CHF2.42 vs FactSet CHF2.33 [5 est, CHF2.19-2.60]

      • HUSQ.B.SS (Husqvarna) -- reports Q2 EPS (ex IAC) SEK2.73 vs FactSet SEK2.24 [6 est, SEK1.99-2.41]

      • TELIA.SS (Telia Co.) -- reports Q2 EPS SEK0.50 vs consensus SEK0.43; reaffirms outlook for 2025

      • BILL.SS (Billerud) -- reports Q2 EPS SEK0.22 vs FactSet SEK0.90 [7 est, SEK0.36-1.41]

      • SZG.GR (Salzgitter) -- reports preliminary Q2 EBIT (€56.5M) vs prior year (€5.7M) vs FactSet €27.9M [1 est]

      • BHG.SS (Lightshop) -- reports H1 EPS SEK0.42 vs year-ago (SEK0.57)

      • MGN.NO (Magnora) -- reports Q2 EPS (NOK0.28) vs FactSet (NOK0.12) [3 est, (NOK0.63)-0.20]

      • BRNK.GR (Branicks Group) -- reports continued strong letting business in H1 with 214,700 sqm total letting performance vs year-ago 181,00 sqm

      • ICEAIR.IR (Icelandair Group) -- reports Q2 net income $12.9M vs year-ago $0.6M

      • KARNEL.B.SS (Karnell Group) -- reports Q2 EPS SEK0.68 vs FactSet SEK0.60 [1 est]

    • M&A

      • FGR.FP (Eiffage) -- VINCI Autoroutes, Eiffage, SFTRF and ATMB enter into exclusive negotiations with Brisa for contemplated sale of 100% of Axxès

      • BRE2.SS (Bredband2 i Skandinavien) -- Telia Co. making recommended offer of SEK3.25/share in cash for Bredband2 i Skandinavien

      • BPMC (Blueprint Medicines) -- Sanofi completes acquisition of Blueprint Medicines

      • ENI.IM (Eni) -- deal to sell 49.99% stake in CCUS Holding will likely value the business at €1B - Bloomberg (17-Jul, 16:43 CET)

      • CLNX.SM (Cellnex Telecom) -- EQT, Omers and Phoenix Tower International exploring final bids for Cellnex Telecom's 72% stake in Swiss business - Bloomberg

      • DG.FP (VINCI SA) -- VINCI reaches agreement to acquire the German group R+S; price not disclosed

      • EURN.BB (CMB.TECH) -- provides update on Golden Ocean merger process; expects to complete merger on or around 20-Aug-25

      • TELIA.SS (Telia Co.) -- signs letter of intent to divest Latvian operations with Republic of Latvia, Latvenergo and LVRTC

      • CVC.NA (CVC Capital Partners) -- seeking to sell its 30% of Moove - Brazil Journal

      • COFA.FP (Coface) -- to acquire Novertur International

      • ECR.SM (Ercros) -- Spain's CNMC conditionally agrees to approve Esseco's offer for Ercros (post EU close 17-Jul)

      • INSE.LN (Inspired) -- Regent announces extension of Long Stop Date to 26-Dec-25 in connection with its cash offer for Inspired PLC

      • ALESE.FP (Entech Smart Energies) -- Entech acquires portfolio of photovoltaic power plant projects under development from world-renowned player for ~€1.4M

      • CAPMAN.FH (Capman) -- exploring sale of stake in Finnish JV with Telia - Bloomberg

    • Healthcare

      • GSK.LN (GSK Plc) -- FDA panel votes against the benefit-risk profile of Blenrep in combo with bortezomib

      • GSK.LN (GSK Plc) -- FDA panel votes against the benefit-risk profile of Blenrep in combo with pomalidomide

      • CANTA.SS (Cantargia) -- announces preliminary topline efficacy results from the phase 2 TRIFOUR trial of nadunolimab in advanced triple-negative breast cancer (TNBC)

      • VIMIAN.SS (Vimian Group) -- announces departure of CEO and President Patrik Eriksson, effective immediately

      • ATT.SS (Attendo) -- to initiate SEK150M share buyback program

    • Other

      • ML.FP (Cie Generale des Etablissements Michelin SA) -- Michelin publishes global tire market data for May

      • VENDA.NO (Vend Marketplaces) -- accepts NOK 10M violation penalty from Finanstilsynet and establishes new practice for pre-close communication

      • HUSQ.B.SS (Husqvarna) -- Group announces Glen Instone appointed CEO of Group

      • CLN.SW (Clariant) -- rejects LyondellBasell's allegations against four companies related to the 2020 competition law infringement

      • NESN.SW (Nestle) -- invests in two new reforestation projects

      • VWS.DC (Vestas Wind Systems) -- Vestas wins 527 MW order in the USA

      • SUBC.NO (Subsea 7) -- Subsea7 awarded large contract from Equinor relating to Fram Sør project offshore Norway

      • TE.FP (Technip Energies) -- and Shell Catalysts & Technologies sign global alliance agreement for carbon capture delivery

      • MB.IM (Mediobanca) -- issues press release with reference to the alleged falsehoods attributed to Nagel in today's press release by the Caltagirone Group

      • EQT-backed cyber insurance group CFC exploring London listing at £5B valuation - FT

      • Follow-up: Heartflow, Inc. files for Nasdaq IPO through J.P. Morgan, Morgan Stanley and Piper Sandler - S-1

      • JUUL Labs notes FDA today issued marketing granted orders for JUUL system (earlier)

      • Regional Gaming Revenues - Pennsylvania June 2025

  • Key rating changes

    • Downgrades

      • VOLV.B.SS (Volvo) -- to hold from buy at SEB, we're told (earlier, timing uncertain)

      • S92.GR (SMA Solar Technology) -- to underperform from hold at Jefferies (earlier, timing uncertain)

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- to sell from hold at Danske Bank

      • ONTEX.BB (Ontex Group) -- to neutral from buy at UBS

  • Data

    • Nikkei (0.17%) to 39832.59

    • Hang Seng +0.79% to 24691.94

    • Shanghai Composite +0.25% to 3525.61

    • S&P futures +15.3 vs prior close of 6340.5

    • €-$ +0.0023 or +0.20% to 1.1619

    • $-¥ +0.16 or +0.10% to 148.76

    • €-¥ +0.51 or +0.30% to 172.83

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE